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BACKGROUND: Trichotillomania (TTM) and skin-picking disorder (SPD) 
have been characterized as body-focused repetitive behavior disorders 
(BFRBs). Because BFRBs frequently co-occur, we sought to discover the 
similarities and differences for individuals having both TTM and SPD as 
opposed to 1 of these disorders.
METHODS: Participants with primary TTM (N = 421) were evaluated regard-
ing the comorbidity of SPD, and participants with primary SPD (N = 124) 
were evaluated regarding the comorbidity of TTM. The effects of comor-
bidity overlap on demographic and clinical measures were evaluated. 
RESULTS: Of the 421 participants with primary TTM, 61 (14.5%) had co-
occurring SPD. Of 124 participants with primary SPD, 21 (16.9%) had 
comorbid TTM. Participants with primary TTM and comorbid SPD had 
significantly more severe trichotillomania symptoms and were more likely 
to have major depressive disorder than those with TTM alone. Participants 
with primary SPD and comorbid TTM reported significantly more severe 
skin-picking symptoms than those who had only SPD. 
CONCLUSIONS: Individuals with co-occurring TTM and SPD may have 
more problematic symptoms with the primary repetitive behavior. Hair 
pullers with comorbid SPD were more likely to have comorbid depres-
sion. Evaluating patients for multiple BFRBs may be important to assess 
the severity of symptoms and may have treatment implications.
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INTRODUCTION
Trichotillomania (TTM) and skin-picking disorder 
(SPD) both have been characterized as body-focused 
repetitive behavior disorders (BFRBs).1-4 Their sug-
gested grouping as BFRBs arises from parallel and 
common features: both disorders occur more fre-
quently among women,5 involve an uncontrolled 
repetitive behavior of excessively grooming oneself,2 
and appear to share some genetic and neurobiological 
overlap.6-8 
TTM and SPD frequently co-occur.3,9,10 In terms of 
clinical presentation, some preliminary research sug-
gests that individuals with co-occurring TTM and SPD 
spend more time engaging in pulling or picking behav-
ior each day compared with patients with TTM alone.11 
In addition, self-reported data from TTM patients 
with comorbid BFRBs also illustrate greater “focused” 
pulling and perceived disability, compared with non-
comorbid cases.3 
Although our clinical understanding of the impact 
of TTM and SPD comorbidity remains limited, more 
extensive research is available exploring relationships 
between other so-termed obsessive-compulsive and 
related disorders (OCRDs). The category of OCRDs, 
now recognized in DSM-5, includes obsessive- 
compulsive disorder (OCD), body dysmorphic dis-
order (BDD), and hoarding disorder, alongside 
TTM and SPD. For example, adults with OCD and 
comorbid BDD demonstrate greater OCD symptom 
severity, earlier age at onset of OCD, as well as higher 
rates of co-occurring depression and anxiety com-
pared with those with OCD alone.12 Similarly, BDD 
patients with comorbid OCD demonstrate greater 
severity of BDD13 but no significant differences in 
age at onset compared with those with BDD alone.14 
Hoarding disorder, a new disorder for DSM-5, has 
received less attention. Collectively, the available 
studies—mostly in OCD—indicate a possible synergis-
tic effect in terms of symptom severity in individuals 
with multiple OCRDs.1 
Given the clinical significance of recognizing 
comorbidity among OCRDs, the aim of the current study 
was to examine whether having co-occurring TTM and 
SPD is associated with greater symptom severity, rates 
of psychiatric comorbidities, and psychosocial dysfunc-
tion than having either TTM or SPD alone.
METHODS
Participants
Data from 421 participants with primary TTM (398 
[94.5%] females; mean age, 28.9 ± 11.6 years) who par-
ticipated in treatment and nontreatment studies from 
2006 to 2016 from the University of Chicago, University 
of Minnesota, and Massachusetts General Hospital were 
included in this study. Additionally, 124 participants 
with primary SPD (109 [87.9%] females; mean age, 33.9 ± 
11.7 years) from the University of Chicago and the 
University of Minnesota who participated in treatment 
and nontreatment studies between 2005 to 2016 were 
included. Study procedures were carried out in accor-
dance with guidelines detailed in the latest version of 
the Declaration of Helsinki. The institutional review 
boards at the University of Chicago, University of 
Minnesota, and Massachusetts General Hospital 
approved the studies and sharing of data, and all par-
ticipants provided written, voluntary informed consent. 
Data were de-identified according to the Safe Harbor 
method for de-identification prior to data sharing 
(§164.514[b]).15 
All participants had a current DSM-IV or DSM-5 
primary diagnosis of TTM or SPD16,17 and were age 13 to 
65. Exclusion criteria at the University of Chicago and 
the University of Minnesota included current preg-
nancy, diagnosis of bipolar disorder or psychosis, and 
inability to provide written consent for participation. 
Exclusion criteria at Massachusetts General Hospital 
included a lifetime diagnosis of psychosis, autism, or 
intellectual disability. All participants underwent a 
detailed psychiatric evaluation using the Structured 
Clinical Interview for DSM-IV (SCID).18 Current 
attention-deficit/hyperactivity disorder (ADHD) 
was assessed at the University of Chicago and the 
University of Minnesota by the participant reporting 
a previous diagnosis by a psychologist or psychiatrist, 
and determined at Massachusetts General Hospital 
using the Kiddie-Sads-Present and Lifetime Version 
(K-SADS) ADHD module. 
Assessments
All participants were asked about their hair-pulling and 
skin-picking behaviors, and this included questions regard-
ing age at onset and duration of illness. For participants 
seen prior to the introduction of DSM-5 in 2013, SPD was 
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assessed using the Skin-Picking Diagnostic Inventory (N. 
J. Keuthen and S. E. Stewart, unpublished) or by the study 
doctor in a direct evaluation using SPD criteria as suggested 
by Arnold et al.19 These criteria largely mirror those formal-
ized in DSM-5.17 SPD was diagnosed only if the subject dis-
played notable picking that resulted in skin lesions. TTM 
was diagnosed using the Trichotillomania Diagnostic 
Interview–Revised20 or by the study doctor using DSM-IV 
or DSM-5 criteria, as appropriate, based on the year in 
which they were assessed. 
The following disorder-specific measures were used: 
• Massachusetts General Hospital Hairpulling Scale 
(MGH-HPS).21 The MGH-HPS is a valid and reliable 7-item 
scale assessing hair-pulling behaviors, urges, control, and 
distress. Each item is scored on a 5-point scale from 0 (no 
symptoms) to 4 (severe symptoms). Total scores range 
from 0 to 28.
• National Institute of Mental Health 
Trichotillomania Severity Scale (NIMH-TSS).22 The 
NIMH-TSS is a valid and reliable scale that asks about 
hair-pulling behaviors in the past week and the previ-
ous day, the ability to resist the urge to pull hair, distress 
associated with hair pulling, and interference with daily 
life due to hair pulling.
• Skin Picking Symptom Assessment Scale 
(SP-SAS).9 The SP-SAS is a valid and reliable 12-ques-
tion scale measuring skin-picking behaviors, thoughts, 
urges, control, and distress in the past week. The ques-
tions are assessed using a 5-point scale, from 0 (none) 
to 4 (extreme). 
• Yale-Brown Obsessive Compulsive Scale Modified 
for Neurotic Excoriation (YBOCS-NE).9,19 The YBOCS-NE is 
a valid and reliable modified version of the YBOCS for SPD 
assessing skin picking in the past week. It has 2 subsections: 
urges and behaviors. Scores range from 0 to 40, with higher 
scores reflective of more severe skin-picking symptoms.
General measures of symptom severity and psycho-
social functioning also were used:
TABLE 1
Primary BFRB alone compared with co-occurring BFRBs on demographic variables





(n = 61) Statistic P Cohen’s d
Sex, n (% female) 340 (94.4%) 58 (95.1%) 0.041a .839 —
Age, years 28.45 (11.6) 31.79 (11.5) 5376.5 .011 .281
Marital status (% single) n = 353, 57 249 (70.5%) 30 (52.6%) 8.506a .075 —
Education, n (%), n = 300, 53
High school or less
Some college









Race (% white), n = 355, 57 325 (91.6%) 54 (94.7%) 3.346a .502 —
Primary SPD alone compared to primary SPD and comorbid TTM
Variable SPD (n = 103)
SPD + TTM
(n = 21) Statistic P Cohen’s d
Sex, n (% female)  91 (88.4%) 18 (85.7%) 0.114a .736 —
Age, years 33.1 (11.4) 38.0 (12.2) 816.5 .077 —
Marital status, n (% single) 55 (53.4%) 10 (47.6%) 0.761a .859 —
Education, n (%), n = 101, 20
High school or less
Some college









Race (% white), n = 101, 19 85 (84.2%) 18 (94.7%) 4.782a .443 —
Note: Mean (SD) unless indicated otherwise; numbers indicate adjusted sample sizes based on availability of data. All statistics are Mann-Whitney U unless indicated otherwise. 
aChi-square.
BFRB: body-focused repetitive behavior disorder; SD: standard deviation; SPD: skin-picking disorder; TTM: trichotillomania.
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• Clinical Global Impression–Severity scale 
(CGI-S).23 The CGI-S assesses overall symptom severity 
using a scale that ranges from 1 (not ill at all) to 7 (among 
the most severe of cases). 
• Sheehan Disability Scale (SDS).24 The SDS evalu-
ates psychosocial dysfunction in 3 domains: work/school, 
social life, and home/family life. 
Data analysis
For purposes of this analysis, participants were 
grouped into 1 of the following 4 groups based on 
their mental health evaluation: (1) primary TTM, (2) 
primary TTM with comorbid SPD, (3) primary SPD, 
and (4) primary SPD with comorbid TTM. In order to 
determine which variables were normally distributed, 
we used the Kolmogorov-Smirnov test. For variables 
that were not normally distributed, the Mann-Whitney 
U test was used to determine differences between the 
groups. For normally distributed variables, an analysis 
of variance was used. The chi-square test was used for 
nonparametric categorical variables. Significance was 
defined as P < .05. Effect sizes also were calculated. 
Effect sizes for the equality of sets of mean differences 
between groups are reported in terms of Cohen’s effect 
size index (d) or, for chi-square analyses, the effect 
sizes are Phi (Φ). A d of 0.2 was considered a small 
effect size; 0.5, medium; and 0.8, large. Phi (Φ) of 0.1 
was considered a small effect size; 0.2, medium; and 
0.3, large. SPSS version 22.0 (IBM Corp) was used for 
all analyses.
RESULTS
In participants with primary TTM, 61 of 421 (14.5%) cases 
had comorbid SPD. In participants with primary SPD, 21 
of 124 (16.9%) cases had comorbid TTM. 
The participants with primary TTM were signifi-
cantly younger than those with primary TTM and comor-
bid SPD. There were no other significant demographic 
findings (TABLE 1).
In terms of clinical variables, those with primary TTM 
and comorbid SPD vs stand-alone primary TTM had a lon-
ger duration of illness (defined as time between first TTM 
symptoms and assessment for this study, P = .004), greater 
TTM symptom severity (reflected by higher total scores 
on the MGH-HPS, P = .004; and higher NIMH-TSS scores, 
P = .036), and were more likely to have current comorbid 
depression (34.4% vs 17.5%, P = .002) (TABLE 2). 
Those participants with primary SPD and comorbid 
TTM, vs stand-alone primary SPD, reported significantly 
later age of SPD onset (P = .027) and greater skin-picking 
symptom severity (reflected by the total SP-SAS score, 
P = .047; and the CGI-S, P = .026) (TABLE 3). 
TABLE 2





(n = 61) Statistic P Cohen’s d
Age at onset, years, n = 350, 60 12.5 (5.8) 11.7 (5.4) 9387.5 .188 —
Duration of TTM, years, n = 350, 60 16.0 (11.96) 20.1 (11.5) 8041.5 .004 0.353
MGH-HPS total, n = 306, 57 15.6 (4.8) 17.4 (4.2) 6659.0 .004 0.393
NIMH-TSS total, n = 337, 40 10.7 (4.0) 12.1 (4.36) 5376.5 .036 0.359
SDS total, n = 270, 53 9.9 (5.7) 10.8 (7.5) 6835.0 .606 —
Current depression, n (%) 63 (17.5%)  21 (34.4%) 9.357a .002 0.305 Phi (Φ)
Current anxiety, n (%), n = 358, 60 92 (25.7%)  19 (31.7%) 0.939a .333 —
Current ADHD, n (%), n = 358, 60 27 (7.5%)  5 (8.3%) 0.150a .698 —
Current BDD, n (%), n = 311, 56 5 (1.6%) 3 (5.4%) 3.129a .077 —
Any current comorbidity other than BFRB, n (%) 185 (51.4%)  38 (62.3%) 2.491a .115 —
Note: Mean (SD) unless indicated otherwise; numbers indicate adjusted sample sizes based on availability of data. All statistics are Mann-Whitney U unless indicated otherwise. 
aChi-square.
ADHD: attention-deficit/hyperactivity disorder; BDD: body dysmorphic disorder; BFRB: body-focused repetitive behavior disorder; MGH-HPS: Massachusetts General  
Hospital Hairpulling Scale; NIMH-TSS: National Institute of Mental Health Trichotillomania Severity Scale; SD: standard deviation; SDS: Sheehan Disability Scale; SPD: skin-
picking disorder; TTM: trichotillomania.
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DISCUSSION
This study examined the clinical significance of having 
co-occurring BFRBs in the largest sample of clinically 
diagnosed adults with these disorders available to date. 
As predicted, BFRB symptom severity was greater in 
those with co-occurring TTM and SPD compared with 
those with either TTM or SPD alone. This finding is con-
sistent with similar analyses in related disorders of OCD 
and BDD,12,13 supporting the importance of careful screen-
ing for comorbidity in clinical practice. 
The comorbid BFRB groups evidenced greater symp-
tom severity than the other 2 groups (small effect size), and 
comorbidity of BFRBs may suggest greater dysfunction of 
underlying neurocircuitry. Neuroimaging research in both 
TTM and SPD suggest abnormally reduced integrity of 
white-matter tracts and structural abnormalities in neu-
ral regions involved in motor generation and suppression 
(such as the anterior cingulate and frontal cortices), while 
functional imaging has illustrated executive planning and 
motor inhibitory deficits, compared with healthy con-
trols.6,7,25-28 It is possible, therefore, that the combination 
of 2 similar disorders may result in additive abnormalities 
or even disproportionately greater than expected struc-
tural abnormalities in regions involved in habit genera-
tion, action monitoring, and top-down inhibitory control 
processes. Future neuroimaging research should consider 
comparing individuals with a single BFRB to those with 
co-occurring BFRBs to fully understand the biological 
substrates of this comorbidity. It also would be valuable 
in future work to compare cognitive functioning between 
such groups. 
From a clinical perspective, the finding of greater 
BFRB symptom severity in the comorbid groups also may 
necessitate changes to current treatment approaches. 
Given that cognitive-behavioral strategies, specifically 
variants of habit reversal therapy, have shown benefit for 
both TTM and SPD separately,29,30 the question remains as 
to whether interventions need to be more frequent, lon-
ger in duration, or different when approaching individu-
als with comorbid TTM and SPD. Also relevant to clinical 
practice is that people with primary TTM who had comor-
bid SPD showed significantly higher rates of major depres-
sive disorder than people with TTM alone (medium effect 
size). Although this cross-sectional study cannot assess 
causality, it appears likely that having these 2 BRFBs pre-
disposes toward high risk of later developing depression, 
rather than vice versa. 
There are several limitations to the current study. First, 
the comorbid BFRB was not examined with its own sever-
TABLE 3





(n = 21) Statistic P Cohen’s d
Age at onset, years 11.8 (7.0) 18.6 (14.8) 743.0 .027 0.585
Duration of TTM, years 21.29 (12.2) 19.43 (13.6) 986.5 .570 —
SP-SAS total, n = 102, 21 28.20 (6.6) 31.38 (6.8) 4.03a .047 0.477
NE-YBOCS total 18.40 (4.9) 20.19 (5.9) 899.0 .223 —
CGI-S 4.22 (0.9) 4.62 (0.7) 789.5 .026 0.510
SDS total 11.32 (6.7)  11.81 (6.7) 0.094 .760 —
Current depression, n (%) 37 (35.9%)  8 (38.1%) 0.036b .850 —
Current anxiety, n (%) 18 (17.5%)  5 (23.8%) 0.463b .496 —
Current ADHD, n (%) 6 (5.8%)  3 (14.3%) 1.855b .173 —
Current BDD, n (%), n = 54, 9 12 (22.2%) 4 (44.4%) 2.011b .156 —
Any current comorbidity other than a BFRB, n (%) 55 (53.4%)  13 (61.9%) 0.510b .475 —
Note: Mean (SD) unless indicated otherwise; numbers indicate adjusted sample sizes based on availability of data. All statistics are Mann-Whitney U unless indicated otherwise. 
aANOVA. 
bChi-square.
ADHD: attention-deficit/hyperactivity disorder; ANOVA: analysis of variance; BDD: body dysmorphic disorder; BFRB: body-focused repetitive behavior disorder;  
CGI-S: Clinical Global Impression–Severity of Illness scale; NE-YBOCS: Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation;  
SD: standard deviation; SDS: Sheehan Disability Scale; SPD: skin-picking disorder; SP-SAS: Skin Picking Symptom Assessment Scale; TTM: trichotillomania.
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ity measure. It could be potentially informative for future 
research to better understand how the level of severity of 
the comorbid BFRB impacts the primary BFRB. Second, 
the samples, although large, lacked ethnic and gender 
diversity. Third, it should be noted that the primary TTM 
with co-occurring SPD group, who were more likely to have 
depression, also were older, and so this finding needs to be 
interpreted with this limitation. How these findings might 
generalize to other populations remains to be explored. 
Lastly, it would be valuable in future work to examine cog-
nitive and neurobiological correlates of comorbid BFRBs, 
as opposed to stand-alone disorders, as the current study 
did not collect such data. 
CONCLUSIONS
This study suggests that the co-occurrence of TTM and 
SPD results in more problematic symptoms with the pri-
mary repetitive behavior. In addition, this study found that 
hair pullers with comorbid SPD were more likely to have 
depression. Evaluation of patients for multiple BFRBs may 
be important in assessing severity of symptoms and may 
have treatment implications. Whether and to what extent 
this co-occurrence necessitates novel treatment interven-
tions awaits future research. ■
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